Prophylactic use of antimalarials during pregnancy

Canadian Family Physician

Volumn 57, Issue 11, 2011, Pages 1279-1281

  Irvine, Marie Hélène ^a   Einarson, Adrienne ^a   Bozzo, Pina ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; DOXYCYCLINE; HYDROXYCHLOROQUINE; MEFLOQUINE; PLACEBO; PRIMAQUINE; TETRACYCLINE;

ACUTE DISEASE; ARTICLE; BIRTH DEFECT; CHEMOPROPHYLAXIS; CONGENITAL MALFORMATION; DRUG SAFETY; DYSPLASIA; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HUMAN; INFECTION PREVENTION; MALARIA; PREGNANCY; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; SIDE EFFECT; SPONTANEOUS ABORTION; STILLBIRTH; TERATOGENICITY; TOOTH DISCOLORATION;

ANTIMALARIALS; ATOVAQUONE; CHEMOPREVENTION; CHLOROQUINE; DOXYCYCLINE; FEMALE; HUMANS; HYDROXYCHLOROQUINE; MALARIA; MEFLOQUINE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PRIMAQUINE; PROGUANIL; TRAVEL;

EID: 81855212521     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. World Health Organization [website]. Malaria. Fact sheet no. 94. Geneva, Switz: World Health Organization; 2010. Available from: www.who.int/ mediacentre/factsheets/fs094/en/index.html. Accessed 2011 Jun 24.
2. Centers for Disease Control and Prevention. CDC health information for international travel 2012. New York, NY: Oxford University Press; 2012. Available from: wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious- diseases- related-to-travel/malaria.htm. Accessed 2011 Sep 14.
3. Committee to Advise on Tropical Medicine and Travel. Canadian recommendations for the prevention and treatment of malaria among international travellers - 2009. Can Commun Dis Rep 2009;35(Suppl 1):1-82.
4. Shulman CE, Dorman EK. Importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg 2003;97(1):30-5. (Pubitemid 36880725)
5. Wolfe MJ, Cordero JF. Safety of chloroquine in chemosuppression of malaria during pregnancy. BMJ (Clin Res Ed) 1985;290(6480):1466-7.
6. Steketee RW, Wirima JJ, Hightower AW, Slutsker L, Heymann DL, Breman JG. The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. Am J Trop Med Hyg 1996;55(1 Suppl):33-41.
7. Villegas L, McGready R, Htway M, Paw MK, Pimanpanarak M, Arunjerdja R, et al. Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double-blind, placebo-controlled trial. Trop Med Int Health 2007;12(2):209-18.
8. Czeizel AE, Rockenbauer M. Teratogenic study of doxycycline. Obstet Gynecol 1997;89(4):524-8. (Pubitemid 27133523)
9. Hellgren U, Rombo L. Alternatives for malaria prophylaxis during the first trimester of pregnancy: our personal view. J Travel Med 2010;17(2):130-2.
10. Phillips-Howard PA, Wood D. The safety of antimalarial drugs in pregnancy. Drug Saf 1996;14(3):131-45. (Pubitemid 26086050)
11. McGready R, Ashley EA, Moo E, Cho T, Barends M, Hutagalung R, et al. A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. J Infect Dis 2005;192(5):846-53. Epub 2005 Jul 27.
12. McGready R, Keo NK, Villegas L, White NJ, Looareesuwan S, Nosten F. Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report. Trans R Soc Trop Med Hyg 2003;97(5):592-4. (Pubitemid 40590101)
13. McGready R, Stepniewska K, Edstein MD, Cho T, Gilveray G, Looareesuwan S, et al. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria. Eur J Clin Pharmacol 2003;59(7):545-52. Epub 2003 Aug 30.
14. Na-Bangchang K, Manyando C, Ruengweerayut R, Kioy D, Mulenga M, Miller GB, et al. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women. Eur J Clin Pharmacol 2005;61(8):573-82. Epub 2005 Jul 23.
15. Pasternak B, Hviid A. Atovaquone-proguanil use in early pregnancy and the risk of birth defects. Arch Intern Med 2011;171(3):259-60.
16. Nosten F, ter Kuile F, Maelankiri L, Chongsuphajaisiddhi T, Nopdonrattakoon L, Tangkitchot S, et al. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study. J Infect Dis 1994;169(3):595-603. (Pubitemid 24063003)
17. Phillips-Howard PA, Steffen R, Kerr L, Vanhauwere B, Schildknecht J, Fuchs E, et al. Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. J Travel Med 1998;5(3):121-6. (Pubitemid 28447572)
18. Vanhauwere B, Maradit H, Kerr L. Post-marketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy. Am J Trop Med Hyg 1998;58(1):17-21. (Pubitemid 28071403)
19. Baird JK, Hoffman SL. Primaquine therapy for malaria. Clin Infect Dis 2004;39(9):1336-45. Epub 2004 Oct 12.